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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A201Results: 56.2% of participants were using NSAIDs for OA, and odds of
use were lower for patients with older age (odd ratio (OR) ¼ 0.97, 95%
Conﬁdence Interval (CI) ¼ 0.95-0.99) and low income status (OR ¼0.42,
95%CI ¼ 0.26-0.68). Almost a quarter (23.6%) were using a simple
analgesic acetaminophen), and use was associated with older age (OR
¼1.03, 95%CI ¼ 1.00-1.05) and higher WOMAC scores (OR ¼1.02, 95%CI
¼ 1.00-1.03).Thirteen percent of participants were using opioids, and
use was more common among those with greater WOMAC scores (OR
¼1.03, 95%CI ¼ 1.01-1.05), and greater BMI (OR ¼1.04, 95%CI ¼ 1.00-
1.08). Just over half (57%) of participants reported they had ever used
topical creams for their OA, and only WOMAC scores were associated
with use (OR¼1.02, 95%CI ¼ 1.01-1.03). About half (55.5%) of partic-
ipants reported they had ever received a joint injection for knee OA; no
patient characteristics we examined were associated with use. Less
than half of patients reported receiving PT for knee OA (39.3%), and this
was associated only with greater OA symptom duration (OR ¼1.03, 95%
CI ¼ 1.00-1.05). Less than half of participants also reported receiving PT
for hip OA (34.6%); no patient characteristics we examined were asso-
ciated with use.
Conclusions: WOMAC score was the characteristic most commonly
associated with treatment use, indicating that patients with greater
symptom severity are more likely to receive a range of conservative
treatments; this is likely a sign of appropriate clinical care. Unlike
studies of joint replacement surgery, we found no racial or gender
differences in use of conservative OA treatments; overall, results did not
show any substantial disparities in care according to patient demo-
graphic characteristics. However, use of PT was low overall in this
cohort of patients with fairly long-standing OA (average of 10 years);
these results suggest efforts are needed to enhance use of PT in real-
world clinical settings, particularly for knee OA where there is a strong
evidence base for effectiveness.
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MY JOINT PAIN: WEB-BASED OSTEOARTHRITIS MANAGEMENT
RESOURCE IMPROVES QUALITY OF CARE
H. Umapathy y, K. Bennell z, C. Dickson x, F. Dobson z, M. Fransen x,
G. Jones ¶, D. Hunter y. y Inst. of Bone and Joint Res., The Kolling Inst., Univ.
of Sydney, Sydney, Australia; zCtr. for Hlth.Exercise and Sports Med., Dept.
of Physiotherapy, Univ. of Melbourne, Melbourne, Australia; xArthritis
Australia, Sydney, Australia; kClinical and Rehabilitation Sci. Res. Group,
Faculty of Hlth.Sci., Univ. of Sydney, Sydney, Australia; ¶Menzies Res.
Inst. Tasmania, Univ. of Tasmania, Tasmania, Australia
Purpose: Despite the availability of evidenced based guidelines for
conservative treatment of osteoarthritis (OA), management is often
constrained to the use of analgesics and waiting for eventual total joint
replacement. This suggests a gap in knowledge of participants with OA
regarding themany different treatments available to them. TheMy Joint
Pain website aims to disseminate evidence based information to better
educate participants with OA, provide management tools aimed to
improve self-management of OA and to direct them to resources that
will facilitate and aid informedmanagement. The objective of this study
is to test the effects My Joint Pain on quality of care and health evalu-
ation impact.
Methods: A classical quasi experimental designwas utilised to evaluate
the independent variable, My Joint Pain, over a 12-month period. The
intervention provided participants with information, monthly check
ups with validated instruments and progress tracking tools. A nation-
wide convenience sample of 195 participants completed baseline and
12-month questionnaires (My Joint Pain Users n¼104, controls n¼91).
There were two main outcome measures used for this study: the
Osteoarthritis Quality Indicator (OAQI) questionnaire to evaluate the
change in appropriateness of care received by participants assessed on
17 items and the Health Evaluation Impact Questionnaire (heiQ) to
evaluate 8 different domains (Health-directed activity; Positive and
active engagement in life; Emotional distress; Self-monitoring and
insight; Constructive attitudes and approaches; Skill and technique
acquisition; Social integration and support; Health service navigation).
Independent T-tests were used to identify changes between groups for
both outcome measures and Chi-square tests were used to identify
change within and between groups from baseline to 12-months for
each OAQI item.Results: Baseline demographics between groups were similar with
distribution of genders (78% female, 22% male), a mean age of 60 and
a mean BMI of 31.1. Following 12-months exposure to the website
compared to the control group, there were signiﬁcant improvements
in self-management (change score ¼ 15.15% vs 1.68%, p ¼ 0.001) and
weight reduction (change score ¼2.51% vs -6.25%, p ¼ 0.026) meas-
ured on the OAQI. Pre-post analysis also showed improvements in
self-management (change score ¼ 15.15%, p ¼ 0.03), lifestyle (change
score ¼ 16.16%, p ¼ 0.02) and physical activity (change score ¼ 10.8%,
p¼ 0.04) in the users of My Joint Pain. With the exception of ‘Health
service navigation’, mean effect sizes of all other heiQ domains
showed a positive trend although were insigniﬁcant in the inter-
vention group.
Conclusions: My Joint Pain improves certain aspects of quality of OA
care received and is a positive intervention. However, further work is
required to improve the engagement of the website and quality of
information to have a greater impact.
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MIXED METHODS EVALUATION OF A COMPREHENSIVE
OSTEOARTHRITIS HIP AND KNEE SERVICE; PATIENT, CLINICIAN
AND ADMINISTRATIVE PERSPECTIVES
B. Cavka, I. Ackerman, M. Tacey, I. Wicks, A. Bucknill, C.A. Brand.
Melbourne Hlth., Parkville, Australia
Purpose: The Osteoarthritis Hip and Knee Service (OAHKS) was
implemented at The Royal Melbourne Hospital (RMH), a major Aus-
tralian tertiary hospital, in 2006 as an innovative new model of care to
improve the management of patients with osteoarthritis through a
multidisciplinary team approach and more effective prioritisation of
joint replacement surgery. This study aims to assess the impacts and
outcomes of the OAHKS using quantitative and qualitativemethodology
to answer the key questions;
) Was OAHKS implemented as planned (service ﬁdelity), and if not
why not?
) What impact has OAHKS had on efﬁciency outcomes, in particular
patient wait times from primary care referral to joint replacement
surgery?
Methods: Mixed methods study design including a pre/post inter-
vention analysis to evaluate wait times, semi structured interviews and
focus groups. The study was approved by the Human Research Ethics
Committee at RMH.
All patients who had undergone a primary elective total hip or total
knee replacement at RMH between 2003-2012 were identiﬁed using
hospital databases (n¼1704). Twenty ﬁve patients who had been
referred from general practice (GP) were randomly selected for each
year, taking into account the proportion of hip versus knee procedures
performed. Data were extracted from medical records including date of
GP referral, date of initial outpatient clinic appointment, date of consent
for surgery, surgery date, patient characteristics (age, gender, require-
ment for an interpreter), health status, and available social support.
Descriptive analysis and non-parametric statistical tests were
performed.
Fifteen current OAHKS patients were interviewed to ascertain their
experience of, and satisfaction with, the service. Focus groups were
undertaken with current OAHKS clinicians: orthopaedic surgeons
(n¼8), rheumatologists (n¼5) and physiotherapists (n¼3). Focus group
discussions targeted work force redesign, triage of OA referrals, and
assessment and monitoring of patients. Interviews of six members of
the original OAHKS project team were undertaken to explore enablers
and barriers to implementation from administrative and clinical per-
spectives. The interviews and focus groups were transcribed and NVivo
10 qualitative data analysis software was used to support identiﬁcation
of emerging themes.
Results: A total of 250 patients were included in the pre/post inter-
vention analysis with no signiﬁcant difference in patient character-
istics between the pre (2003-2005) and post (2007-2012) OAHKS
implementation periods. When considering the post OAHKS imple-
mentation period (2007-2012), the median wait time from GP referral
to initial appointment was 81 days (IQR: 51-141) compared to 105 days
(IQR: 79-136) pre OAHKS implementation (p¼0.02). Additionally, wait
times for patients triaged to OAHKS versus the orthopaedic clinic
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patients waited a shorter time for their initial appointment (median:
63 versus 93 days, p<0.01) and once consented for surgery, OAHKS
patients waited a shorter time for their procedure (median 141 versus
218 days, p<0.01).
Interview data demonstrated that patients reported high levels of
satisfaction with the OAKHS particularly related to the education
provided regarding their condition and optimisation of non operative
management. There was consensus amongst clinicians that the OAHKS
is a valuable service which facilitates timely access to intervention and
minimises inappropriate surgical referrals. Project team members
identiﬁed orthopaedic surgeon engagement was critical to the serv-
ice’s success. They were highly satisﬁed the project had been imple-
mented as initially planned. Inclusion of experienced clinicians,
academics, and hospital management and government representatives
facilitated the development of a comprehensive and sustainable model
of care.
Conclusions: Implementation of the OAHKS at RMH has improved
access to care for patients with hip and knee osteoarthritis through
reduction of key wait times. Qualitative data indicate that patients and
clinicians are highly satisﬁed with this model of care and highlights
potential reasons for its success/sustainability.
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COMPARISON OF TOTAL KNEE REPLACEMENT COSTS BETWEEN 2005
AND 2010
K. Wang. Peking Univ. People's Hosp., Beijing, China
Purpose: To analyse changes in hospitalization costs for total knee
replacement(TKR) during 5 years by comparing those of 2005 and 2010,
evaluate the role of clinical pathway in controlling hospitalization cost
and to provide the basis for reasonable control of medical cost.
Methods: We retrospectively analyzed the data of patients undergoing
unilateral and bilateral total knee replacement in 2005 and 2010 in
Peking University People's Hospital.There were 72 unilateral and 92
bilateral total knee replacement cases in 2005, whereas the number of
those in 2010 was 265 and 206 respectively. All charges were assigned
to 1 of 9 categories: hospital room, nursing, radiology and laboratory,
prosthesis, blood transfusion, surgery, pharmacy, treatment, diagnosis.
We compared the total costs and cost of each category between 2005
and 2010.
Results: There was no statistical signiﬁcant difference between 2005
and 2010 in terms of age, gender distribution, primary disease and
type of prosthesis. The total costs for unilateral and bilateral TKR was
8173.25 dollar and 14257.64 dollar in 2010, respectively. They were
both signiﬁcantly lower than those of 2005(9007.98 dollar and
14962.18 dollar respectively). The charge for each category of TKR in
2010 was 91.81, 23.72, 506.96, 384.4, 302.82, 804.84, 25.25, 869.72, and
6878.1 dollar. Compared with 2005, Each category of charge dropped
in 2010, especially the cost of surgery, diagnosis and hospital room,
which decreased by 55.41%, 33.45%, 37.33% respectively. The tendency
of change in charge of unilateral and bilateral TKR was similar to the
overall costs.
Conclusions: The total costs for TKR in 2010 were lower than those of
2005, which might be the result of adopting Clinical Pathway(CP) since
2010. Nevertheless, the prosthesis cost accounted for a large proportion
in both years. Therefore, controlling the prosthesis cost is an effective
way to reduce medical costs for TKR.
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COMPARISON OF KNEE OSTEOARTHRITIS TREATMENT IN THE NON-
OBESE VS OBESE POPULATIONS ACROSS DIFFERENT MEDICAL
SPECIALTIES
K. Forrester, F. Tauﬁq, J. Samuels. NYU Langone Hosp. for Joint Diseases,
New York, NY, USA
Purpose: Knee osteoarthritis (KOA) in the obese population is
under-diagnosed and often under-treated when identiﬁed. Providersoften attribute knee pain to excess weight without considering
articular pathology, and they are less likely to believe that obese
patients will comply with treatment recommendations. The liter-
ature to date does not specify if patients in different BMI/obesity
subgroups (non-obese vs obese, BMI 29.9 kg/m2 vs 30 kg/m2) are
offered or suggested the same treatment options for their KOA pain.
Here we look retrospectively at the approaches to KOA treatment
across the 2 BMI subgroups, with respect to use of acetaminophen,
non-steroidal anti-inﬂammatory drugs (NSAIDs)/COX-2 inhibitors,
physical therapy, intra-articular steroid injections, and intra-articu-
lar hyaluronic acid (HA) injections. We also compare the approaches
to treatment of KOA in obesity between the ﬁve physician specialties
of rheumatology, orthopedics, sports medicine, physiatry, and
internal medicine.
Methods: We conducted a search of the electronic medical record
between January 1 and December 31, 2013 for patients seen by the 5
physician specialties at New York University Langone Medical Center.
The study selected patients with ICD-9 codes for “knee osteoarthritis,”
“osteoarthritis,” and “knee pain.” From the resulting list of 4,486
patients, we have reviewed the ﬁrst 750 charts and selected for clinical
and radiographic KOA while excluding patients with bilateral knee
replacements, trauma within 6 weeks, or concurrent rheumatoid
arthritis, psoriatic arthritis, gout, pseudogout, or bursitis. From this
initial cohort of 750 we found 105 whomet criteria (25 patients seen by
rheumatologists, 26 by orthopedists, 28 by sports medicine, 12 by
physiatrists, and 14 by internists). After recording BMIs, demographics,
comorbidities, KOA characteristics, and KOA management, we analyzed
patterns of the 5 types of treatment for the 2 BMI subgroups, and by
physician specialty.
Results: The preliminary cohort of 105 patients had an overall mean
BMI of 30.6 ±7.1 and mean age of 62.3 ±14.3 years with 85.6%
females. We identiﬁed 51 non-obese patients with BMI <30 and 54
obese patients with a BMI 30. We found some differences between
the BMI-stratiﬁed treatment patterns when including all specialists
together. Physicians overall were more likely to offer HA injections to
non-obese patients than to obese patients (69.4% vs. 26.7%) - but
conversely administered intra-articular steroid injections to obese
patients more often than to non-obese patients (47% vs. 14%).
Physicians did not treat the BMI subgroups differently with regards
to acetaminophen use, NSAID use, or physical therapy referral.
Rheumatologists prescribed more NSAIDs/ COX-2 inhibitors to non-
obese patients than to those with a BMI 30 (64% vs 40%). Internal
medicine physicians prescribed more acetaminophen to non-obese
patients (57% vs 33%), but there was no difference in the other
specialties. Multiple specialties prescribed more HA viscosupple-
mentation injections to non-obese patients compared to obese,
including rheumatology (35% vs 13%), orthopedics (33% vs 15%), and
internal medicine physicians (33% vs 0%). All specialties prescribed
intra-articular steroid injections to obese patients more often than
non-obese patients (47% vs 14%). Rheumatologists and sports medi-
cine physicians referred more patients in general to physical therapy
(74% and 96%) compared to orthopedists, physiatrists, and internal
medicine physicians (62%, 60%, and 62%, respectively). Additionally,
rheumatologists prescribed more acetaminophen and NSAIDs than
the other specialties combined (52% vs 14% and 56% vs 46%,
respectively).
Conclusions: Our pilot data suggests a difference in KOA treatment
between non-obese and obese patients, and often between physi-
cian specialties. Obese pateints are more likely to receive steroid
injections but less likely to receive HA injections were recom-
mended less often to obese patients than to non-obese patients.
Rheumatologists more often prescribe non-invasive treatments
compared to orthopedists, physiatrists, and internal medicine
physicians, while we found that sports medicine physicians refer
more patients to physical therapy. Identiﬁcation of these divergent
KOA treatment patterns of obese patients as well as between spe-
cialists warrants discussion to optimize algorithms across muscu-
loskeletal care.
